Molecule.one grows its drug synthesis AI platform with a $4.6M seed round
TechCrunch
JUNE 1, 2021
Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. The company’s system enters play when you have some exotic new compound you want to make in order to test it in real life, but don’t know how to make it.
Let's personalize your content